Video Experimental Relacionado
Updated: Aug 18, 2026
05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
La mortalidad y el consumo de alcohol ligero a moderado después del infarto de miocardio
J Muntwyler1, C H Hennekens, J E Buring
1Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Lancet (London, England)
|December 24, 1998
Resumen
El consumo de alcohol ligero a moderado está relacionado con una menor mortalidad total en hombres con antecedentes de infarto de miocardio. Este estudio sugiere un efecto protector potencial del consumo moderado de alcohol en este grupo de pacientes.
Área de la Ciencia:
- Salud Cardiovascular La salud cardiovascular.
- Epidemiología La epidemiología.
- Investigación sobre el alcohol Investigación sobre el alcohol
Sus antecedentes:
- El consumo excesivo de alcohol se asocia con un aumento de la mortalidad.
- La ingesta leve a moderada de alcohol puede disminuir la mortalidad en individuos sanos.
- Existen datos limitados sobre el efecto del alcohol en la mortalidad en pacientes después de un infarto de miocardio.
Objetivo del estudio:
- Investigar la relación entre el consumo de alcohol ligero a moderado y la mortalidad en hombres con un infarto de miocardio previo.
- Para abordar la escasez de datos en esta población específica de pacientes.
Principales métodos:
- Estudio prospectivo en el que participaron 90.150 hombres del Estudio de Salud de los Médicos.
- Se incluyeron 5.358 hombres con un infarto de miocardio previo y sin antecedentes de cáncer, accidente cerebrovascular o enfermedad hepática.
- El consumo de alcohol estimado utilizando un cuestionario de frecuencia de los alimentos.
Principales resultados:
- Un seguimiento medio de 5 años observó 920 muertes.
- La ingesta moderada de alcohol mostró una disminución significativa en la mortalidad total (p=0,016) después del ajuste de confusión.
- Los riesgos relativos para la mortalidad total disminuyeron con el aumento de la ingesta moderada de alcohol (por ejemplo, 0,72 para 2-4 bebidas / semana).
Conclusiones:
- Los hombres con infarto de miocardio previo que consumen cantidades pequeñas a moderadas de alcohol experimentan una menor mortalidad total.
- Los hallazgos sugieren un beneficio potencial de supervivencia del consumo de alcohol ligero a moderado en esta cohorte.
Videos de Conceptos Relacionados
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...